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An H7N2 subtype avian influenza virus (AIV) first appeared in the live bird marketing system (LBMS) in the Northeastern United States in
1994. Since then this lineage of virus has become the predominant subtype of AIV isolated from the LBMS and has been linked to several costly
commercial poultry outbreaks. Concern for this low pathogenicity isolate mutating to the highly pathogenic form has remained high because of the
increasing number of basic amino acids at the hemagglutinin (HA) cleavage site, which is known to be associated with increased pathogenicity of
AIV. To address the risk of low pathogenic LBMS-lineage H7N2 virus mutating to the highly pathogenic form of the virus, we generated a series of
mutant viruses that have changes in the sequence at the HA cleavage site by using plasmid-based reverse genetics. We confirmed that a conserved
proline at −5 position from the HA cleavage site could be changed to a basic amino acid, producing a virus with five basic amino acids in a row at
the cleavage site, but with no increase in virulence. Increased virulence was only observed when additional basic amino acids were inserted. We also
observed that the virus preferred the arginine instead of lysine at the −4 position from the cleavage site to manifest increased virulence both in vitro
and in vivo. Using helper virus-based reverse genetics, where only one transcription plasmid expressing a mutated HAvRNA is used, we identified
specific HA cleavage site sequences that were preferentially incorporated into the low pathogenic wild-type virus. The resultant reassortant viruses
were highly pathogenic in chickens. This study provides additional evidence that H7 avian influenza viruses require an insertional event to become
highly pathogenic, as compared to H5 viruses that can become highly pathogenic strictly by mutation or by insertions.
Published by Elsevier Inc.Keywords: Avian influenza virus; H7N2 subtype; Pathogenicity; Reverse geneticsIntroduction
The live bird marketing system (LBMS), especially in the
Northeastern region of the United States, has been the source of
most of the avian influenza virus (AIV) isolations during the
past decade (Panigrahy et al., 2002; Suarez et al., 2003). The
isolations included primarily H5, H6, and H7 subtype viruses,
but also many other subtypes of AIV. The H7 subtype virus first
appeared in the northeastern LBMS in 1994 and since then it
has been the predominant subtype of AIV isolated. The H7N2
subtype virus in the LBMS is well adapted to poultry and has
served as a source of infection for commercial poultry⁎ Corresponding author. Fax: +1 706 546 3161.
E-mail address: dsuarez@seprl.usda.gov (D.L. Suarez).
0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2006.06.003(Spackman et al., 2003). This included the outbreak in Virginia
in 2002 which resulted in 197 poultry flocks being depopulated
at a direct federal cost of over 60 million dollars to control the
outbreak.
There are 16 different hemagglutinin (HA) subtypes of
influenza viruses (Fouchier et al., 2005), but infections with
viruses of theH5andH7subtypes areof themost concernbecause
of thepotential for theseviruses tomutate to thehighlypathogenic
form of the virus. Although we cannot predict which low
pathogenic viruses will remain low pathogenic and which will
mutate to become highly pathogenic, previous epornitics of
highly pathogenic avian influenza demonstrated that low
pathogenic precursor H5 and H7 subtype viruses, when allowed
to circulate in poultry for an extended period of time, can undergo
mutational changes that can result in the emergence of highly
Table 1
Five different HA cleavage site sequences observed in the LBM-lineage H7N2
avian influenza virus isolates since 1994a
a The data was updated from the report by Spackman et al., (2003).
b Basic amino acids (Lysine(K) and Arginine(R)) are in bold character.
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al., 1995;Bankset al., 2001;Hirst et al., 2004;Suarez et al., 2004).
The determinant of pathogenicity of influenza virus is not
totally defined. The virulence of influenza virus is polygenic,
but it is acknowledged that the HA protein plays a pivotal role in
determining pathogenicity, at least in chickens and turkeys
(Garten and Klenk, 1999; Steinhauer, 1999). More specifically,
posttranslational cleavage of the precursor HA molecule into
HA1 and HA2 subunits generates a fusogenic domain at the
amino terminus of HA2, which mediates fusion between the
viral envelope and the endosomal membrane. Thus, proteolytic
activation of the HA is essential for virus infectivity and spread
of the virus (Klenk et al., 1975). The HAs of low pathogenicity
AIVs, which cause localized infection in the respiratory or
intestinal tract, are usually cleaved only in a restricted number
of cell types. In contrast, the highly pathogenic virus causes a
lethal systemic infection, and its HA is activated by proteases
present in a broad range of different host cells.
Two key structural features are known to determine the HA
cleavability: the amino acid sequence at the cleavage site and
glycosylation near the cleavage site. Highly pathogenic viruses,
which have HAs with high cleavability, have multiple basic
amino acids (lysine and arginine) at their cleavage sites (Bosch
et al., 1981). Loss of glycosylation at position 11, which is
located near the cleavage site in the virus's three-dimensional
structure, was related to the high pathogenicity of the A/chicken/
PA/1370/83 (H5N2) virus reported in the United States in 1983
(Kawaoka et al., 1984; Deshpande et al., 1987; Ohuchi et al.,
1989). Loss of the carbohydrate chain near the HA cleavage site
is assumed to be related to the increased accessibility of the
protease to the cleavage site for HA cleavage.
In most reported cases of highly pathogenic avian influenza,
the highly pathogenic virus was detected within a year from the
first detection of the low pathogenicity precursor virus (Webster
et al., 1986; Horimoto et al., 1995; Banks et al., 2001; Hirst et
al., 2004; Suarez et al., 2004). In several cases, the highly
pathogenic virus was detected almost at the same time as the
low pathogenicity virus. The LBMS-lineage H7N2 virus has
been circulating for over 10 years and fortunately still remains
as the low pathogenic form of the virus. However, a previous
study indicated that the HA cleavage site sequence, a marker for
pathogenicity in chickens and turkeys, is progressing toward a
cleavage site sequence that fulfills the molecular criteria for
highly pathogenic AIV (Spackman et al., 2003). In this study, to
address the risk of the LBMS-lineage H7N2 virus mutating to
the highly pathogenic form of the virus, we generated a series of
reassortant viruses that had changes in the sequence at the HA
cleavage site by using reverse genetics. In vitro and in vivo
characteristics of those reassortant viruses are described.
Results
HA gene features of the LBMS-lineage H7N2 viruses
Sequence analysis of the HA1 gene of the LBMS-lineage
H7N2 viruses showed that there are three potential glycosylation
sites at position 12, 28, and 231 (or 223 for the LBM-lineageH7N2 viruses isolated after 1996which have the eight amino acid
deletion from residues 212 to 219 (Suarez et al., 1999)) in most of
the H7N2 isolates sequenced that were sampled since 1994 (data
not shown). The glycosylation at these positions is conserved
among H7 viruses and all the known highly pathogenic H7
viruses possess potential glycosylation sites at these locations.
Additional glycosylation sites were observed at position 149 or
287 from other individual H7N2 isolates, respectively.
Sequence analysis of the HA cleavage sites showed that
viruseswith seven different sequencemotifs have been circulating
since 1994 (Table 1). The cleavage site sequences of the majority
of the earlier isolates (N–P–K–T–R or N–P–K–P–R) had only
one basic amino acid other than arginine at −1 position. However,
in 1998, isolates that had two more basic amino acids at the
cleavage site (K–P–K–P–R) were first observed and became the
predominant sequence in the LBM-lineage H7N2 isolates. In
early 2002, viruses with three basic amino acids at the cleavage
site (K–P–K–K–R) were observed resulting in four of five amino
acids at the cleavage site being basic. We detected larger number
of isolates with these multiple basic amino acids at the HA
cleavage site in 2004 (29 isolates) and 2005 (50 isolates). Viruses
with unusual cleavage site sequences (R–P–K–P–R and K–P–
K–P–K) were also reported from a couple of isolates,
respectively, in 2004 and 2005.
Comparison of the H7 HA cleavage site sequence with other
highly pathogenic viruses
Based on previous reports, most H7 subtype low patho-
genicity viruses generally have a P–E–X–P–K–X–R motif,
where X indicates any nonbasic amino acid, with one more
basic amino acid (Lysine) other than Arginine at the cleavage
site (Table 2). Although the recent LBM-lineage H7N2 virus
has three lysines at −5, −3, and −2 positions at the cleavage
site, the sequence still belongs to a low pathogenicity
consensus motif. In contrast to the low pathogenicity virus,
all the reported highly pathogenic viruses have at least a two
additional amino acid insertions, usually a basic amino acid,
between proline and arginine. Several recent highly pathogenic
viruses show unusual amino acid insertions, some of which are
known to occur by intersegmental recombination (Suarez et al.,
2004; Pasick et al., 2005).
Table 2
Comparison of the HA cleavage site sequence of the H7 subtype avian influenza viruses
a
X indicates any nonbasic amino acid.
b Unusual amino acid insertions are underlined. Isolates from Chile and Canada are known to acquire underlined insertion of amino acids from NP and M1 genes
by recombination, respectively.
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characterization of the rescued reassortant viruses with
mutated HA gene
To elucidate possible amino acid changes that can increase
the virulence of the low pathogenicity H7N2 virus, we
introduced a series of mutations and insertions in the HA gene
of A/chicken/NJ/150383/02 isolate by in vitro mutagenesis and
rescued the reassortant viruses that contained those mutated HA
genes by plasmid-based reverse genetics (Table 3). We included
the reassortant viruses that had the same HA sequence of the
known highly pathogenic AIV, A/chicken/Chile/4977/02, as a
positive control. All the reassortant viruses created by reverse
genetics replicated similarly well in embryonating chicken eggs
(ECE) (106.9–107.9 EID50/ml) (Table 3).
We first switched the Proline (P) at the −4 position from the
cleavage site to arginine (R) or lysine (K). So, the reassortant
viruses (rg-1 and rg-2) contained five basic amino acids in a row
(KRKKRorKKKKR) at the cleavage site.We found that Proline
at −4 position, which is highly conserved among H7 viruses,
could be replaced by basic amino acids without reduced
replication efficiency in vitro. However, we did not see any
change in virulence compared to the reassortant virus that had
the parent HA sequence (rg-parent) both in vitro (determined by
embryo mortality and plaque forming efficiency) and in vivo
(determined by intravenous pathogenicity test).
We also found that the reassortant viruses preferred
arginine instead of lysine at the −4 position from the
cleavage site. Reassortant viruses that had a lysine insertion
at the −4 position (rg-4 and rg-6) showed inefficient plaque
formation in chicken embryo fibroblast (CEF) cells and
reduced pathogenicity both in vitro and in vivo compared to
the viruses that had an arginine insertion at the same position
(rg-3 and rg-5).
As expected, insertion of basic amino acids increased the
virulence of the reassortant viruses as evidenced by shortened
mean death time (MDT) in ECE and efficient plaque formationin CEF cells in the absence of exogenous trypsin. Insertion of
two additional lysines (rg-7 and rg-8) increased the virulence of
the virus but these viruses were less virulent than the one that
had a single arginine insertion (rg-3). The reassortant viruses
with 3 more basic amino acids (rg9) clearly manifested
increased virulence compared to the viruses that had 1 or 2
basic amino acid insertions.
We also changed lysine at the −5 position into 3 different
amino acids (rg-10, rg-11, rg-12) based on the sequence of
known highly pathogenic viruses. We did not observe any
difference in pathogenicity among reassortant viruses with
different sequences at this position either in vitro or in vivo
(Table 3).
Helper virus-based reverse genetics and characterization of the
reassortant viruses
To further confirm the pathogenicity of viruses with different
HA cleavage site sequences, we applied helper virus-based
reverse genetics, where only one transcription plasmid expres-
sing a mutated HA vRNA is used. A detailed procedure is
described in the Materials and methods section. Using this
method, we identified that specific HA cleavage site sequences
were preferentially incorporated into the low pathogenicity wild-
type virus (Table 4). Interestingly, several HA genes with
cleavage site sequences that conferred highly pathogenic
phenotypes of viruses rescued using plasmid-based reverse
genetic systems were not incorporated into the backbone of the
helper virus. All the reassortant viruses created by helper virus-
based reverse genetics replicated efficiently in chickens and
produced 100% mortality.
Discussion
H7N2 subtype AIV has been circulating for more than
10 years as a predominant subtype in the Northeastern United
States. Considering the potential of low pathogenic H5 and H7
Table 3
In vitro and in vivo characteristics of the reverse-genetic viruses
a The challenge doses were adjusted to 104 EID50/0.2 ml and 10
6 EID50/0.2 ml for the pathogenicity test in ECE and chickens, respectively.
b PFU (plaque forming unit): – indicates no plaque formation.
c MDT (mean death time), average number of days required to kill the inoculated eggs.
d Number of birds that manifested clinical signs/number of birds inoculated. + mild, ++ severe, +++ very severe.
e Number of birds that died/number of birds inoculated. MDT is indicated in parentheses.
f The mean virus titer is express as the log10 EID50/ml ± standard deviation. Number of positive samples are indicated in parentheses.
g Log2 hemagglutination inhibition titer (mean titer of sera collected from the surviving birds 10 days after challenge) ± standard deviation.
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Table 4
In vitro and in vivo characteristics of the helper virus-based reverse-genetic viruses
a The challenge doses were adjusted to 104 EID50/0.2 ml and 10
6 EID50/0.2 ml for the pathogenicity test in ECE and chickens, respectively.
b PFU: plaque forming unit.
c MDT (mean death time), average number of days required to kill the inoculated eggs.
d Number of birds that died/number of birds inoculated.
e MDT (mean death time), average number of days required to kill the inoculated chickens.
f The mean virus titer is express as the log10 EID50/ml ± standard deviation. Number of positive samples are indicated in parentheses. – indicates no live birds
were available at 3 DPI for virus re-isolation and titration.
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are allowed to circulate in poultry for an extended period of
time, it is fortunate that this LBM lineage H7 virus still remains
a low pathogenicity virus. However, a previous report by
Spackman et al. warns us that concern for this low pathogenic
isolate mutating to the highly pathogenic form remains high
because of the increasing number of basic amino acids at the
hemagglutinin (HA) cleavage site, which is known to be
associated with increased pathogenicity of AIV.
We wanted to find out the sequence requirements and
possible combinations of the amino acid sequence at the HA
cleavage site for low pathogenicity LBMS-lineage H7N2
viruses to acquire high virulence. To do this, we generated a
series of reassortant viruses that had changes in the sequence at
the HA cleavage site by using in vitro mutagenesis coupled with
plasmid-based reverse genetics.
First, we switched the conserved proline residue at the −4
position from the cleavage site to arginine or lysine. The
resultant reassortant viruses (rg-1 and rg-2) thus had five
consecutive basic amino acids (KRKKR or KKKKR) at the
cleavage site. This mutation was introduced not only to detect
a change in pathogenicity but also to determine if this mutation
allowed for efficient replication of the virus. In a previous
study (Vey et al., 1992), the conserved Proline residues at this
position were not shown to be important for cleavability of the
HA protein. However, the previous study only used the simian
virus 40 system and tested only for their cleavability by an
endogenous protease in CV-1 cells (simian kidney cell-derived
fibroblasts), to determine if the mutation of conserved Proline
to other amino acids could be tolerated by the virus for
efficient replication remained unclear. We found that proline at
the −4 position could be replaced by basic amino acids and
tolerated without reduced replication efficiency of the virus.
Although the resultant virus had five basic amino acids at the
cleavage site, the observation of inefficient plaque formation in
CEF cells in the absence of trypsin indicated inefficient
cleavage of the HA molecule. When we compared virulence of
the virus with such mutations to that of the virus with theparent HA sequence (rg-parent), no change in pathogenicity
phenotype was observed in chickens (Table 3).
Second, we found that mutated viruses with a single insertion
at the −4 position from the cleavage site preferred arginine
instead of lysine, and mutated viruses that had a lysine insertion
at −4 position (rg-4 and rg-6) showed inefficient plaque
formation in CEF cells and reduced pathogenicity compared
to the viruses that had an arginine insertion at the same position
(rg-3 and rg-5). Our result is consistent with the previous
observation by Vey et al., that the amino acid at position −4
from the cleavage site of the A/FPV/Rostock/34 virus has to be
arginine for efficient HA cleavage to occur. Although the
majority of the known highly pathogenic viruses have arginine
at −4 position, there are some highly pathogenic viruses with
lysine at this position (Table 1). Thus, it appears that in
particular cases, the HA structure allows a lysine at position −4.
It also appears that the acceptability of lysine at −4 position is
related to the overall three-dimensional structure of the HA and
not determined only by the HA cleavage site sequence; we tried
different HA cleavage site sequences that resembled known
highly pathogenic viruses in this study (rg-3, rg-5, rg-7, and rg-
8) and all of them manifested a low pathogenicity phenotype
(Table 2 and 3).
Third, we inserted up to three more basic amino acids at the
HA cleavage site. It should be noted that all known highly
pathogenic viruses arose by inserting more basic amino acids
between the conserved proline and arginine at the cleavage site.
Viruses that had an arginine insertion caused increased mortality
both in vitro (indicated by shortened mean death time in ECE
and efficient plaque formation in the absence of the trypsin) and
in vivo (indicated by clinical signs in chickens) (Table 3). The
increased virulence of the virus was more obvious with
reassortants that had three more basic amino acid insertions.
Insertion of one or two lysines also increased the virulence of
the virus compared to the reassortant that had the parent HA
sequence (rg-parent). However, those reassortant viruses were
less virulent than the virus that had a single arginine insertion.
We expect that it has to do with the decreased cleavage
393C.-W. Lee et al. / Virology 353 (2006) 388–395efficiency of the virus that had lysine instead of arginine at −4
position as mentioned above.
Fourth, we changed lysine at −5 position of the parental
virus into isoleucine (I), asparagine (N), or threonine (T) based
on the sequence of known highly pathogenic viruses. We did
not observe differences in virulence among these reassortants.
This observation may indicate the presence of basic amino
acid (K) at −5 position of a recent LBM-lineage H7N2 virus
has nothing to do with its potential to become a highly path-
ogenic virus.
Although we observed distinctly different pathogenicities
among different reassortant viruses created by plasmid-based
reverse genetics in terms of clinical signs in chickens, those
reassortant viruses demonstrated limited replication in chick-
ens compared to the parent wild-type virus and could not
produce 100% mortality (Table 3). The clinical signs of
chickens infected with several reassortant viruses (rg-9, rg-10,
rg-11, and rg-12) were as severe as we normally see with
other known highly pathogenic viruses. In a previous study,
we also observed the limited growth of reverse genetically
created reassortant viruses in chickens (Lee et al., 2005).
Although all the internal genes and the neuraminidase gene of
the reverse genetic viruses were derived from a highly
pathogenic avian origin viruses, we speculate that the optimal
combination of genes were not present for the efficient
replication in chickens and reinforces the previous idea that
virulence of AIV is polygenic.
To further confirm the pathogenicity of virus with different
HA cleavage site sequences, we applied helper virus-based
reverse genetics, where only one transcription plasmid
expressing a mutated HA vRNA is used. The remaining
vRNAs are provided by the helper virus. Using this method,
we discovered that specific HA cleavage site sequences were
preferentially incorporated into the low pathogenic wild-type
virus (Table 4). Interestingly, several HA genes with cleavage
site sequences that conferred a highly pathogenic phenotype of
viruses rescued using plasmid-based reverse genetic systems
were not incorporated into the backbone of the helper virus.
The main difference between the plasmid-based and the helper
virus-based reverse genetics systems is the presence or
absence of competition between the parental and the newly
introduced HA vRNA. As a result, we presume that some HA
sequences with specific mutations that were viable in plasmid-
based reverse genetics were not competitive enough and were
excluded in the helper virus system. In this context, this helper
virus-based reverse genetic system may represent and closely
mimic the positive selection event that can happen in a real
situation. Furthermore, in contrast to the plasmid-based
reverse genetic viruses, all the reassortant viruses created by
helper virus-based reverse genetics replicated efficiently in
chickens and produced 100% mortality. It should also be
emphasized that, unlike other known highly pathogenic virus,
a single arginine insertion at the HA cleavage site was enough
for this low pathogenic LBM-lineage virus to convert to the
highly pathogenic form.
So, will the future highly pathogenic avian influenza outbreak
virus have the specific HA sequences identified in this study?Obviously, much more extensive mutagenesis studies need to be
done to make any conclusion. Nevertheless, our study provides
potential combinations of the amino acid sequence at the HA
cleavage site of viruses that are viable and that may be selected as
potential HA sequences of a future highly pathogenic virus.
Materials and methods
Viruses
The A/chicken/NJ/150383/02 (H7N2) isolate was received
from the National Veterinary Services Laboratories, Ames,
Iowa, and maintained in the virus repository at the Southeast
Poultry Research Laboratory, Athens, Georgia. The virus was
received in allantoic fluid after single passage in ECE (Swayne
et al., 1998). The virus was passaged one additional time in ECE
to make a working stock.
Preparation of the HA cDNA and sequence confirmation
Viral RNA was extracted with Trizol LS reagent (Life
Technologies, Rockville, MD) from infectious allantoic fluid
fromECE. The full-length protein coding region sequences ofHA
viral RNA segment of the A/chicken/NJ/150383/02 virus was
determined by cycle sequencing (PRISM Ready Reaction
DyeDeoxy Terminator Cycle Sequencing Kit; Perkin-Elmer,
Foster City, CA), following amplification by standard RT-PCR
using the Qiagen one-step RT-PCR kit (Qiagen, Valencia, Calif.).
Plasmid construction and site-directed mutagenesis
We generated a transcription plasmid by inserting amplified
HA cDNAofA/chicken/NJ/150383/02 isolate into pHH21 vector
between the promoter and terminator sequences of RNA
polymerase I (Lee et al., 2004; Neumann et al., 1999). The
transcription plasmids that contain the remaining 7 gene segments
were previously prepared (Lee et al., 2005). The M, NS, PA, and
PB2 genes originated from the A/chicken/Indonesia/7/03 (H5N1)
virus, and the NA, NP and PB1 genes originated from the A/duck/
Anyang/AVL-1/01 (H5N1) virus (Tumpey et al., 2002; WHO,
2005), respectively. We used these previously made transcription
plasmids to expedite the research. In addition, we cloned a HA
gene of the A/chicken/Chile/4977/02 (H7N3) HPAI virus (Suarez
et al., 2004) into the pHH21 vector.
We used the pHH21 plasmid that contained the H7 gene of
A/chicken/NJ/150383/02 isolate as a template to introduce a
series of mutations by using the Quick-Change site-directed
mutagenesis kit (Stratagene, La Jolla, CA).
Generation of reverse genetic reassortant viruses
Reassortant viruses were generated by DNA transfection as
described previously (Lee et al., 2004; Neumann et al., 1999).
Briefly, 293T cells were transfected with 1 μg of each of the
eight transcription plasmids and four expression plasmids with
the use of Lipofectamine 2000 reagent (Invitrogen, San Diego,
Calif.). After 48 h of incubation, supernatant was collected
394 C.-W. Lee et al. / Virology 353 (2006) 388–395and subsequently inoculated into 10- or 11-day-old ECE. After
48 h of incubation, allantoic fluid containing reassortant virus
was harvested and stored at −70 °C for additional experi-
ments. The identity of the reassortant virus was confirmed by
partial sequencing of each viral segment.
In vitro and in vivo characterization of reverse genetic viruses
The growth of the rescued viruses was determined in 10-day-
old ECE and CEFs. Evaluation of plaque forming efficiency
was performed in CEFs with trypsin (0.3 μg/ml) and without
trypsin, as previously described (Swayne et al., 1998). To
calculate the mean death time (MDT) of the embryos, 104
EID50/0.2 ml dose of each virus was inoculated into 15 10-day-
old ECEs and observed for 7 days for mortality.
Groups of 8 4-week-old SPF White Leghorn (WL) chickens
were used in the chicken IV pathogenicity test with reverse
genetic reassortant viruses. One of the groups was inoculated
with A/chicken/NJ/150383/02 parent virus for comparison.
Oropharyngeal swabs were collected from four live birds in
each group on day 3 p.i. Morbidity and mortality were observed
for 10 days and sera were collected from all birds at the end of
the experiment to determine the antibody level to the HA by the
hemagglutination inhibition (HI) test (Swayne et al., 1998).
Helper virus-based reverse genetics
Eighty percent confluent 293T cells were transfected with
1ug of transcription plasmid that contained mutated HA
sequences, together with 4 expression plasmids with the use of
Lipofectamine 2000 reagent (Invitrogen). Twenty-four hours
after cotransfection, cells were infected with the parent A/
chicken/NJ/150383/02 virus (MOI = 1.0). Forty hours after
infection, the supernatants of the infected cells were collected
and used to infect CEF cells. Reassortant viruses in the
supernatants were screened by sequencing the virus from
plaques formed in the CEF cells. Because the helper virus
does not form plaques in CEFs, the presence of plaques
indicated the reassortant virus contains the mutated HA gene.
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